SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-084772
Filing Date
2004-05-11
Accepted
2004-05-11 16:45:19
Documents
14
Period of Report
2004-03-27

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 412552
2 LICENSE AND OPTION AGREEMENT dex101.htm EX-10.1 239224
3 AMENDMENT NO 1 TO LICENSE AND OPTION AGREEMENT dex102.htm EX-10.2 12301
4 AMENDMENT NO 2 TO LICENSE AND OPTION AGREEMENT dex103.htm EX-10.3 19588
5 AMENDMENT NO 3 TO LICENSE AND OPTION AGREEMENT dex104.htm EX-10.4 93457
6 LETTER AGREEMENT dex105.htm EX-10.5 45340
7 AMENDMENT TO EMPLOYMENT AGREEMENT dex106.htm EX-10.6 10533
8 AMENDMENT TO EMPLOYMENT AGREEMENT dex107.htm EX-10.7 13292
9 LETTER AGREEMENT dex108.htm EX-10.8 28093
10 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9544
11 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9552
12 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4128
13 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4142
14 RISK FACTORS dex991.htm EX-99.1 136832
  Complete submission text file 0001193125-04-084772.txt   1041931
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
OSCIENT PHARMACEUTICALS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-10824 | Film No.: 04796870
SIC: 2835 In Vitro & In Vivo Diagnostic Substances